Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Enveric Biosciences Inc. (ENVB)

  • Technical Exchange News
  • Oct. 29, 2025, 19:32 UTC
  • 69
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 08:54 UTC
  • 77
  • 0 comments

Tourmaline Bio Inc (TRML) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 72
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Tourmaline Bio, Inc. - Common Stock. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 72
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 67
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Entero Therapeutics Inc. (ENTO)

  • Technical Exchange News
  • Oct. 29, 2025, 01:46 UTC
  • 62
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 68
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Tourmaline Bio, Inc. - Common Stock. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 71
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 60
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Entero Therapeutics Inc. (ENTO)

  • Technical Exchange News
  • Oct. 28, 2025, 19:23 UTC
  • 79
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 398
  • 399
  • 400
  • 401
  • 402
  • Next

Search

News categories

  • Technical Exchange News(14277)
  • Event(6229)
  • SEC News(370767)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(227246)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin